Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments - Narrative (Details)

v3.22.2.2
Fair Value of Financial Instruments - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended 27 Months Ended
Sep. 02, 2021
Sep. 30, 2022
Sep. 30, 2022
Jun. 30, 2022
Apr. 14, 2022
Subsidiary, Sale of Stock [Line Items]          
Decrease of fair value in the committed equity facility     $ 140    
Price per share (in dollars per share)   $ 2.38 $ 2.38    
Unused capacity   $ 19,300 $ 19,300    
Decrease in fair value of private warrant liability     16,005    
Private Warrants          
Subsidiary, Sale of Stock [Line Items]          
Decrease in fair value of private warrant liability   $ 900 $ 16,005    
Committed Equity Facility          
Subsidiary, Sale of Stock [Line Items]          
Derivative asset       $ 800  
Shares from transaction (in shares) 8,500,000 598,854 909,669 127,751  
Sale of stock, amount authorized to issue and sell         $ 80,000
Decrease of fair value in the committed equity facility   $ 100 $ 140    
Percentage of purchase price per share         97.00%
Percentage of commission on gross proceeds         3.00%
Remaining shares available   8,090,331 8,090,331    
Committed Equity Facility | Minimum          
Subsidiary, Sale of Stock [Line Items]          
Price per share (in dollars per share)   $ 2.73 $ 2.73    
Committed Equity Facility | Maximum          
Subsidiary, Sale of Stock [Line Items]          
Price per share (in dollars per share)   $ 4.29 $ 4.29